{"id":381395,"date":"2020-11-16T06:47:46","date_gmt":"2020-11-16T11:47:46","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381395"},"modified":"2020-11-16T06:47:46","modified_gmt":"2020-11-16T11:47:46","slug":"nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/","title":{"rendered":"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">OSLO, Norway<\/span>, <span class=\"xn-chron\">Nov. 16, 2020<\/span> \/PRNewswire\/ &#8212; Nordic Nanovector ASA (OSE: NANO) announces that its Interim CEO, Dr <span class=\"xn-person\">Lars Nieba<\/span> will present a corporate overview, via live webcast, and host one-on-one meetings with investors at the Jefferies Virtual London Healthcare Conference, taking place <span class=\"xn-chron\">17-19 November 2020<\/span>. <\/p>\n<p>Presentations details are as follows:<\/p>\n<p>Jefferies Virtual London Healthcare Conference<br \/>Date: Thursday, <span class=\"xn-chron\">19 November 2020<\/span><br \/>Time: <span class=\"xn-chron\">2:40 to 3:10PM (GMT)<\/span><\/p>\n<p>The company presentation will be available on Nordic Nanovector&#8217;s Investors and Media\u00a0page at the same time. <\/p>\n<p>\n        <b>For further information, please contact:<\/b>\n      <\/p>\n<p>\n        <b>IR enquiries <\/b>\n      <\/p>\n<p>\n        <b>Malene Brondberg, CFO<\/b><br \/>\n        <b><br \/>\n          <br \/>\n          <b>Cell: +44 7561 431 762<\/b><br \/>\n          <br \/>\n          <b>Email: <\/b><br \/>\n        <\/b><br \/>\n        <a target=\"_blank\" href=\"mailto:ir@nordicnanovector.com\" rel=\"nofollow noopener noreferrer\">ir@nordicnanovector.com<\/a><br \/>\n        <b>\u00a0<\/b>\n      <\/p>\n<p>\n        <b>Media Enquiries <\/b>\n      <\/p>\n<p>\n        <b><br \/>\n          <span class=\"xn-person\">Mark Swallow<\/span>\/Frazer Hall\/<span class=\"xn-person\">David Dible<\/span> (Citigate Dewe Rogerson)<\/b><br \/>\n        <b><br \/>\n          <br \/>\n          <b>Tel: +44 203 926 8535<\/b><br \/>\n          <br \/>\n          <b>Email: <\/b><br \/>\n        <\/b><br \/>\n        <a target=\"_blank\" href=\"mailto:nordicnanovector@citigatedewerogerson.com\" rel=\"nofollow noopener noreferrer\">nordicnanovector@citigatedewerogerson.com<\/a><br \/>\n        <b>\u00a0<\/b>\n      <\/p>\n<p>\n        <b>About Nordic Nanovector:<\/b>\n      <\/p>\n<p>Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector&#8217;s lead clinical-stage candidate is Betalutin<sup>\u00ae<\/sup>, a novel CD37-targeting radioimmunotherapy designed to advance the treatment of non-Hodgkin&#8217;s lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly <span class=\"xn-money\">USD 29 billion<\/span> by 2026. Nordic Nanovector retains global marketing rights to Betalutin<sup>\u00ae<\/sup> and intends to actively participate in the commercialisation of Betalutin<sup>\u00ae<\/sup> in the US and other major markets. <\/p>\n<p>Further information can be found at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2982716-1&amp;h=3950296582&amp;u=http%3A%2F%2Fwww.nordicnanovector.com%2F&amp;a=www.nordicnanovector.com\" rel=\"nofollow noopener noreferrer\">www.nordicnanovector.com<\/a>.<\/p>\n<p>\n        <i>This information is subject to a duty of disclosure pursuant to Sections 4-2 and 5-12 of the Securities Trading Act.<\/i>\n      <\/p>\n<p>This information was brought to you by Cision <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2982716-1&amp;h=4195602470&amp;u=http%3A%2F%2Fnews.cision.com%2F&amp;a=http%3A%2F%2Fnews.cision.com\" rel=\"nofollow noopener noreferrer\">http:\/\/news.cision.com<\/a><\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2982716-1&amp;h=215820439&amp;u=https%3A%2F%2Fnews.cision.com%2Fnordic-nanovector%2Fr%2Fnordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference%2Cc3237807&amp;a=https%3A%2F%2Fnews.cision.com%2Fnordic-nanovector%2Fr%2Fnordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference%2Cc3237807\" rel=\"nofollow noopener noreferrer\">https:\/\/news.cision.com\/nordic-nanovector\/r\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference,c3237807<\/a>\n      <\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference-301173509.html\">http:\/\/www.prnewswire.com\/news-releases\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference-301173509.html<\/a><\/p>\n<p>SOURCE  Nordic Nanovector<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=IO92716&amp;Transmission_Id=202011160644PR_NEWS_USPR_____IO92716&amp;DateId=20201116\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire OSLO, Norway, Nov. 16, 2020 \/PRNewswire\/ &#8212; Nordic Nanovector ASA (OSE: NANO) announces that its Interim CEO, Dr Lars Nieba will present a corporate overview, via live webcast, and host one-on-one meetings with investors at the Jefferies Virtual London Healthcare Conference, taking place 17-19 November 2020. Presentations details are as follows: Jefferies Virtual London Healthcare ConferenceDate: Thursday, 19 November 2020Time: 2:40 to 3:10PM (GMT) The company presentation will be available on Nordic Nanovector&#8217;s Investors and Media\u00a0page at the same time. For further information, please contact: IR enquiries Malene Brondberg, CFO Cell: +44 7561 431 762 Email: ir@nordicnanovector.com \u00a0 Media Enquiries Mark Swallow\/Frazer Hall\/David Dible (Citigate Dewe Rogerson) Tel: +44 203 926 8535 Email: nordicnanovector@citigatedewerogerson.com \u00a0 About Nordic Nanovector: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire OSLO, Norway, Nov. 16, 2020 \/PRNewswire\/ &#8212; Nordic Nanovector ASA (OSE: NANO) announces that its Interim CEO, Dr Lars Nieba will present a corporate overview, via live webcast, and host one-on-one meetings with investors at the Jefferies Virtual London Healthcare Conference, taking place 17-19 November 2020. Presentations details are as follows: Jefferies Virtual London Healthcare ConferenceDate: Thursday, 19 November 2020Time: 2:40 to 3:10PM (GMT) The company presentation will be available on Nordic Nanovector&#8217;s Investors and Media\u00a0page at the same time. For further information, please contact: IR enquiries Malene Brondberg, CFO Cell: +44 7561 431 762 Email: ir@nordicnanovector.com \u00a0 Media Enquiries Mark Swallow\/Frazer Hall\/David Dible (Citigate Dewe Rogerson) Tel: +44 203 926 8535 Email: nordicnanovector@citigatedewerogerson.com \u00a0 About Nordic Nanovector: &hellip; Continue reading &quot;Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-16T11:47:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference\",\"datePublished\":\"2020-11-16T11:47:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO92716&amp;sd=2020-11-16\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/\",\"name\":\"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO92716&amp;sd=2020-11-16\",\"datePublished\":\"2020-11-16T11:47:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO92716&amp;sd=2020-11-16\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO92716&amp;sd=2020-11-16\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference - Market Newsdesk","og_description":"PR Newswire OSLO, Norway, Nov. 16, 2020 \/PRNewswire\/ &#8212; Nordic Nanovector ASA (OSE: NANO) announces that its Interim CEO, Dr Lars Nieba will present a corporate overview, via live webcast, and host one-on-one meetings with investors at the Jefferies Virtual London Healthcare Conference, taking place 17-19 November 2020. Presentations details are as follows: Jefferies Virtual London Healthcare ConferenceDate: Thursday, 19 November 2020Time: 2:40 to 3:10PM (GMT) The company presentation will be available on Nordic Nanovector&#8217;s Investors and Media\u00a0page at the same time. For further information, please contact: IR enquiries Malene Brondberg, CFO Cell: +44 7561 431 762 Email: ir@nordicnanovector.com \u00a0 Media Enquiries Mark Swallow\/Frazer Hall\/David Dible (Citigate Dewe Rogerson) Tel: +44 203 926 8535 Email: nordicnanovector@citigatedewerogerson.com \u00a0 About Nordic Nanovector: &hellip; Continue reading \"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-16T11:47:46+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference","datePublished":"2020-11-16T11:47:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/","name":"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16","datePublished":"2020-11-16T11:47:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO92716&amp;sd=2020-11-16"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-to-present-at-upcoming-jefferies-virtual-london-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nordic Nanovector to Present at Upcoming Jefferies Virtual London Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}